BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

講師

Tom Diethe

​​


Session 11 – AI for Pharma

Date:26 July (Friday)
Time09:05 – 09:20 (GMT+8)

Tom Diethe

Head of The Centre for Artificial Intelligence
​​
AstraZeneca, Cambridge UK

​​​​​

Dr Tom Diethe is Head of The Centre for Artificial Intelligence (Executive Director) at AstraZeneca, Cambridge UK. Tom’s department sits within the Data Science & Artificial Intelligence organisation, which is part of the wider BioPharmaceuticals R&D. The team’s mission is to devise innovative products and solutions using machine learning algorithms that will make the drug discovery pipeline more efficient and aid in a better understanding of biology and medicinal chemistry.

Improving AI Analytical and Predictive Power in Drug Discovery Through Deep Learning Methodologies and Industry Collaboration

In this talk, Dr. Tom Diethe, Head of The Centre for Artificial Intelligence at AstraZeneca, will discuss how deep learning methodologies and industry collaboration can improve the analytical and predictive power of AI in drug discovery. 

Dr. Diethe will explore the potential of deep learning techniques to extract valuable insights from complex data sets, and how these insights can be used to accelerate the drug discovery process. He will also discuss the importance of collaboration between industry players in sharing data and knowledge to drive innovation in the field.

Attendees will gain an understanding of the latest developments in AI and deep learning in drug discovery, and how these technologies are being used to drive innovation and improve outcomes for patients. (TW-29562)

​​